The fledgling investment fund Teza Technologies isn't exactly off to a promising start. First one of its employees was accused of stealing codes from Goldman Sachs's trading operations. Then Citadel sued, claiming that three Teza execs who once worked for Citadel breached their noncompete agreements. On Friday, in a motion to dismiss, Teza called those allegations entirely unfounded. Why? Because Teza, which hasn't begun operations, isn't yet competing with Citadel.

Apple's lawyers at WilmerHale have claimed that Nokia manipulated industry standards-setting groups to assure cell phone makers would have to use Nokia technology. Hmm. Where have we heard that before?

Las Vegas may be a tough town on gamblers, but jurors there appear bent on showering plaintiffs with winnings in litigation over a hepatitis C outbreak tied to packaging of the sedative propofol.

Dealing a blow to defense counsel at Skadden, the court resurrected shareholder derivative claims that Baxter's board cost the company at least $550 million by failing to address chronic problems with its Colleague line of infusion pumps.